The DEA Plans to Ban Opioid-Like Kratom Compound 7-OH
The DEA plans to temporarily classify 7-OH, a potent kratom derivative, as a Schedule I controlled substance due to public health risks. This move follows intense scrutiny of the unregulated kratom market and its political connections.
Why it matters
This regulatory action impacts the growing supplement industry and highlights the intersection of federal drug policy and political lobbying.
The Drug Enforcement Administration plans to temporarily ban 7-OH, a component of kratom that has opioid-like effects and is sold in gas stations and smoke shops around the country in the form of gummies, drinks, and capsules.
The report provides factual details on the DEA's intent while noting the industry's political ties, maintaining a balanced investigative tone.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in